Mechanism of Purinergic Activation of Endothelial Nitric Oxide Synthase in Endothelial Cells
Mechanism of Purinergic Activation of Endothelial Nitric Oxide Synthase in Endothelial Cells
复制标题
DOI:
10.1161/circulationaha.108.764571
复制
发表时间:
2009-02-17
期刊:
影响因子:
37.8
通讯作者:
Kaczmarek, Elzbieta
中科院分区:
文献类型:
--
作者:
da Silva, Cleide Goncalves;Specht, Anke;Kaczmarek, Elzbieta
Background-Decreased endothelial nitric oxide (NO) synthase (eNOS) activity and NO production are critical contributors to the endothelial dysfunction and vascular complications observed in many diseases, including diabetes mellitus. Extracellular nucleotides activate eNOS and increase NO generation; however, the mechanism of this observation is not fully clarified.Methods and Results-To elucidate the signaling pathway(s) leading to nucleotide-mediated eNOS phosphorylation at Ser-1177, human umbilical vein endothelial cells were treated with several nucleotides, including ATP, UTP, and ADP, in the presence or absence of selective inhibitors. These experiments identified P2Y1, P2Y2, and possibly P2Y4 as the purinergic receptors involved in eNOS phosphorylation and demonstrated that this process was adenosine independent. Nucleotide-induced eNOS phosphorylation and activity were inhibited by BAPTA-AM (an intracellular free calcium chelator), rottlerin (a protein kinase C delta inhibitor), and protein kinase C delta siRNA. In contrast, blockade of AMP-activated protein kinase, calcium/calmodulin-dependent kinase II, calcium/calmodulin-dependent kinase kinase, serine/threonine protein kinase B, protein kinase A, extracellular signal-regulated kinase 1/2, and p38 mitogen-activated protein kinase did not affect nucleotide-mediated eNOS phosphorylation.Conclusions-The present study indicates that extracellular nucleotide-mediated eNOS phosphorylation is calcium and protein kinase C delta dependent. This newly identified signaling pathway opens new therapeutic avenues for the treatment of endothelial dysfunction. (Circulation. 2009;119:871-879.)